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Abstract
The AU-rich-element (ARE)–mediated mRNA degradation activity of the RNA-binding K-
homology Splicing Regulator Protein (KSRP) is regulated by phosphorylation of a serine within
its N-terminal KH domain (KH1). In the cell phosphorylation promotes the interaction between
KSRP and 14-3-3ζ protein and impairs the ability of KSRP to promote the degradation of its RNA
targets. Here we examine the molecular details of this mechanism. We report that phosphorylation
leads to the unfolding of the structurally atypical and unstable KH1, creating a site for 14-3-3
binding. Using this site 14-3-3 discriminates between phosphorylated and non phosphorylated
KH1, driving the nuclear localization of KSRP. 14-3-3–KH1 interaction regulates the mRNA
decay activity of KSRP by sequestering the protein in a separate functional pool. This study
demonstrates how an mRNA degradation pathway is connected to extra cellular signaling
networks by the reversible unfolding of a protein domain.
INTRODUCTION
Gene regulation by adenosine-uridine-rich element (ARE)-mediated mRNA decay (AMD) is
important for physiological cellular proliferation, immune response and cardiovascular
toning. Indeed AMD malfunction has been linked to cancer1 and to inflammatory diseases
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such as Crohn-like inflammatory bowel disease and inflammatory arthritis2. The effect of
cis-acting AREs on the stability of specific mRNAs is mediated by the binding of regulatory
proteins (ARE-binding proteins, ARE-BPs). Some of these proteins (e.g. TPP, BRF1,
KSRP) promote mRNA degradation while others (e.g. HuD and HuR) act antagonistically,
stabilizing the mRNA3. The rate of decay of these mRNAs is therefore controlled by the
interplay between different protein effectors.
K-homology splicing regulator protein/fuse binding protein 2 (KSRP/FBP2) is an important
ARE-BP (also called turnover and translation regulatory BPs (TTR-BPs4), that has been
shown to recruit the exosome to a subset of mRNA targets, promoting their degradation5,6.
The central part of the protein is organized in four single stranded nucleic acid binding
domains, the so-called K-homology domains (Figure 1a, KH1 to 4). Using cross-linking and
mRNA decay assays, we have shown that the third and fourth KH domain of KSRP are
required for mRNA binding and degradation6. We have also examined the ability of KH3
and KH4 to bind AU-rich sequences using in vitro biophysical assays; this study clarified
that binding by more than one domain is necessary to attain high affinity7.
Recently two independent phosphorylation events that link KSRP-mediated mRNA
degradation to extra cellular regulatory networks have been identified8,9. Phosphorylation of
a threonine in the C-terminal region of KSRP (Thr692) by p38 MAPK is necessary to
regulate the decay of ARE-containing myogenic mRNAs8, while phosphorylation of a serine
(Ser193, Figure 1b) within the first KH domain of KSRP by AKT/PKB kinase reduces the
degradation rate of a subset of mRNAs encoding RNA binding proteins, signalling
molecules and a replication-independent histone9,10. The two phosphorylation events are
regulated by different pathways and produce distinct molecular effects. While Thr692
phosphorylation mediates a change in the ARE binding capabilities of KSRP8, Ser193
phosphorylation does not influence directly the binding to the target AREs but prevents
KSRP from recruiting the exosome9.
We have previously shown that the impairment of exosome recruitment is mediated by the
binding of the 14-3-3ζ protein to the Ser193-phospho-KSRP9. 14-3-3 is a ubiquitous
regulatory protein that has been reported to bind more than 100 targets, most of them
phosphorylated linear peptidic chains within larger proteins11-14. In the most common
mode of interaction the phosphorylated amino acid and a few neighbouring residues lay
along the concave surface of 14-3-3 in an extended conformation and are recognised by the
side chains of the protein residues. This interaction can be disrupted by specific inhibitors
(e.g. difopein) that can be used to confirm the relevance of 14-3-3–target interactions in a
range of regulatory processes. Interestingly, 14-3-3 has been shown to regulate stress
granule formation and mRNA decay when associated with the phosphorylated ARE-BP
TTP15. The 14-3-3 TTP target sequence is closely related to that of KSRP16, but it is
located in an unfolded area of the protein and not, as in the case of KSRP, within an RNA-
binding domain. KSRP Ser193 lies within the sequence boundaries of the first KH domain
(KH1) and a conformational rearrangement may be necessary to allow the recognition of the
phospho-serine and the neighbouring amino acids by 14-3-3.
In order to understand the effect of Ser193 phosphorylation at the molecular level, we have
determined the structure and dynamics of human KSRP KH1 and defined its relationship
with the other domains of the protein and with the AU-rich RNA targets. We have then
probed the structural changes caused by phosphorylation of Ser193 in vitro using NMR
spectroscopy and showed that phosphorylation destabilises the domain, creating a binding
site for 14-3-3. The mechanism of phosphorylation and role of the phosphate group are
analysed with the help of data on the conformation/stability of a phospho-mimic S193D
mutant and a control S193A mutant. We also show that phospho-KH1 interacts directly and
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specifically with 14-3-3 in vitro and phosphorylation of Ser193 causes a 14-3-3-dependent
alteration of the nuclear/cytoplasmic distribution of the protein. Our work indicates that
KH1 acts as a switch in the mRNA decay activity of KSRP by shifting the protein between
distinct sub-cellular pools, and leads to a novel regulatory model that may be applicable to
other 14-3-3 targets.
RESULTS
KH1 structure, inter-domain interactions and RNA recognition
The solution structure of KSRP KH1 (Ile130–Gly218) contains a classical KH fold, with
three α-helices packed against a three-stranded anti-parallel β sheet in a βααββα topology
(Figure 2a, b) typical of the eukaryotic KH type 1 family. This canonical KH fold is well
defined by the NOE data except for the GXXG and variable loops. These loops undergo
motions on millisecond and nano-to-picosecond timescales respectively that have been
linked with the RNA binding ability of the domain17-19.
In KH1, the central KH core is extended by a novel thirteen-residue N-terminal element that
folds back to form a short anti-parallel fourth strand (β0) and augments the exposed surface
of the sheet, reaching the proximity (4-5 amino acids) of the bi-partite Nuclear Localization
Signal (NLS) of KSRP (Figure 1a) .A self-consistent set of individually assigned long range
NOE cross-peaks between this conserved (Figure 1b) N-terminal extension and the core KH
fold - including the correlations between Ser132 HN and Glu148 HN and Gln133 Hα and
Glu147 Hα - was instrumental in packing the strand against the core KH domain. Addition
of β0 is consistent with the appreciable difference in the global rotational correlation time
(τc) of KH1 with and without the N-terminal extension (6.5 ns versus 5.1 ns, respectively;
Supplementary Table 1a) and contrasts with the much smaller (0.6-0.7 ns) increase in τc
observed upon addition of the longer KH12 linker to either KH1 or KH2 (Supplementary
Table 1a). However, nano-to-picosecond motions are observed for the N-terminal extension
(Supplementary Fig. 1a) hinting at substantial flexibility.
The interaction between the canonical β-sheet and the N-terminal extension, is stabilized by
a network of H-bonds involving residues of β0, of β1 and of the β0-to-β1 turn (turn0) (Figure
2c). However, it does not bury hydrophobic side chains (Figure 2d) and is associated with a
very small change in stability, as observed in our CD thermal unfolding studies
(Supplementary Figure 1b). A structural homology search using both the DALI server20 and
a local structure-based alphabet21,22, confirmed that loop-turns structurally similar to the N-
terminal extension can be found in very different structural and functional contexts but is
observed here for the first time adjacent to a KH domain.
Interactions between neighboring KH domains of the Nus A, Vg1RBP and FMRP
proteins23-25 have been reported to influence their structure and stability. To investigate the
possibility of an interaction between KH1 and the other KH domains of KSRP we
superimposed the 15N-HSQC NMR spectra of the KH1 and KH2 substantial chemical shift
differences, indicates that KH1 and KH2 do not interact in a stable and specific way.
Further, KH1 resonances do not change in the four-domain construct indicating that no extra
contacts are made in KH1234 (Supplementary Fig. 2). The absence of a stable KH1–KH2
interaction is validated by NMR relaxation data and by thermal unfolding. The trend of 15N
T1 and T2, and 15N{1H} NOE values along the protein sequence (Figure 3b) is similar in
KH1, KH2 and KH12 while the 14-residue KH1–KH2 linker is very flexible
(Supplementary Fig. 1a). The moderate increase in the rotational correlation time (τc)
observed in the two-domain construct (Supplementary Table 1a) is not consistent with the
two domains tumbling as a stable single unit26. Thermal unfolding studies by CD and NMR
show that the transition mid-point of KH1 and KH2 unfolding does not change appreciably
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in the two-domain construct (Figure 3c, Supplementary Table 1b and data not shown),
confirming that KH1130–218 is an adequate structural model for our studies. Interestingly,
thermal unfolding indicates that KH1 is not only much less stable than KH2 (Supplementary
Table 1b) but also substantially less stable than KH3 and KH47.
Chemical-shift perturbation mapping showed that the interaction of KH1 with short AU-rich
RNA targets7 does not involve the β0-turn0 element but occurs within the previously
defined19,27 KH1 canonical nucleic acid binding groove (Supplementary Fig. 3). However,
the affinity of the interaction is too low to be accurately measured (Kd higher than 1 mM)
and substantially lower of the one of KH2 (Kd = 398 ± 47 μM) (data not shown), KH4 (Kd =
270 ± 30 μM) and KH3 (Kd ~ 125 ± 3 μM) (7) for the same sequences. The low affinity of
KH1 for AU-rich sequences indicates that the domain probably plays a secondary role - if
any - in ARE recognition.
KH1 phosphorylation acts as a conformational switch
In the KH1 structure Ser193 is positioned in the central part of the β-sheet and it cannot be
recognized by 14-3-3ζ in a classical phospho-dependent way. We used NMR to directly test
the effect of Ser193 phosphorylation on the conformation of KSRP KH1. We established a
simple protocol that allowed us to use commercial AKT enzyme to phosphorylate wild type
KH1 to ~90% efficiency. We then purified the two (phospho and non-phospho) species
using a size exclusion column and analyzed them by mass spectrometry.
Supplementary Fig. 4 shows the chromatogram of a size exclusion column loaded with the
phosphorylation reaction and the results of the mass spectrometry analysis of the two peaks.
The higher mobility of the phospho-protein is consistent with an increase of apparent protein
volume due to the unfolding of the domain. High sensitivity SOFAST 15N-1H HMQC
spectra28 were recorded on samples from the two HPLC peaks (Figure 4a): the two spectra
clearly show that the non-phosphorylated protein is folded, while the phosphorylated protein
is essentially unfolded. The amide resonances of phosphoKH1 are in the random coil region
of the spectrum and show a pH-dependent broadening (Supplementary Fig. 5) typical of
exposed amides resonances in exchange with the bulk water. The folding state of phospho-
KH1 was confirmed by recording CD spectra at different temperatures (20, 40, 60, 80 and
95 °C) (Figure 4b). The spectrum of the protein does not change with temperature and the
analysis of the secondary structure components show that the apparent percentage of
unfolded peptidic chain at 20 °C (79.9 %) is in the range expected for fully unfolded
proteins (69.8-89.9 %)29. The S193A mutant was used as a control: no detectable
phosphorylation was observed in a reaction identical to the one described above. Similarly,
no phosphorylation or unfolding was observed in a reaction with thermally inactivated
kinase and wild type protein (data not shown).
In the cell, regulation by phosphorylation is a reversible process. To assess the reversibility
of the changes induced by Ser193 phosphorylation, the phosphorylated protein was de-
phosphorylated using protein λ phosphatase. A SOFAST 15N-1H HMQC spectrum was
recorded on the phosphatase-treated sample, showing that the removal of the phosphate
group leads to complete refolding of the protein (Figure 4c).
In order to better dissect the effect of introducing a phosphate group on the structure and
stability of KH1 we mutated Ser193 to both alanine and aspartate and used NMR to assess
the conformation and stability of the mutants. 15N-1H HSQC experiments recorded on the
S193A mutant showed a well-dispersed spectrum similar to that of the KH1 wild type
construct (Figure 5a). Changes in the spectrum were limited to resonances of amides in the
immediate proximity of the mutated residue. Further, thermal unfolding of the mutant was
followed by CD which confirmed that its stability is similar to that of the wild type domain
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(Figure 5b). This indicates that the conserved serine has a functional rather than a structural
role. Conversely, mutation of the serine to the phospho-mimic aspartate drastically changed
the stability of the protein. The 15N-1H HSQC spectrum of the mutant recorded at 27°C
shows that the protein exist as an equilibrium mixture of folded and unfolded species
(Figure 5a) and that the spectrum of the folded form is very similar to that of the wild type
KH1, with changes being consistent with a S193D point mutation. NMR spectra recorded at
both lower and higher temperature showed, as expected, a reversible shift of the folded/
unfolded equilibrium towards the unfolded species (Supplementary Fig. 6). CD spectra
confirmed that the mutant is undergoing both cold and high temperature unfolding and that,
even at the point of maximum stability (15°C) only ~70% of the protein is folded (data not
shown). Introduction of a negative charged side chain at position 193 severely destabilizes
the domain, confirming the role of the phosphate group in domain unfolding.
14-3-3ζ–Phospho-KH1 recognition
Our data indicate that phosphorylation of KH1 unfolds the domain and creates a site for
14-3-3 binding. We wanted to analyze the interaction between 14-3-3ζ protein and the
phosphorylated and unfolded KSRP KH1 domain using SOFAST 15N-1H HMQC spectra.
Initially we titrated unlabelled 14-3-3 into a sample of unmodified 15N-labelled KH1: no
change takes place in the fingerprint spectra of the domain, indicating that the two proteins
are not interacting (Figure 6a). In contrast, when unlabelled 14-3-3 is added to the
phosphorylated KH1 we observe a strong selective decrease in the intensity of the NMR
signal of a small number of resonances (Figures 6a and 6b). This observation is consistent
with 14-3-3 interacting with a short target sequence within the phosphorylated domains. We
expect that, because of the interaction with the large 14-3-3 protein, the resonances of
residues directly involved in the binding would broaden very markedly, possibly beyond
detection. Non-neighboring residues that are separated from the 14-3-3 binding site by a
flexible stretch of several amino acids would be shielded from the effect of the molecular
weight increase and will undergo very moderate broadening. To confirm that this model is
applicable to our data and to show that the 14-3-3-KH1 interaction is indeed mediated by a
short unfolded and phosphorylated amino acid stretch we have used a 10-fold excess of a
phospho-peptide that spans the KH1 14-3-3 target sequence (GLPERSVSpLTGAPES) to
compete out 14-3-3 protein. Upon addition of the peptide to the 14-3-3-KH1 complex, the
KH1 resonances that had undergone selective broadening re-appeared in the spectra (Figures
6a and 6b).
To directly explore the role of the phosphate group in 14-3-3 recognition of the peptidic
sequence defined above we have compared the binding of the KH1 phospho and non-
phosphopeptides of that sequence to 14-3-3ζ by isothermal titration calorimetry (ITC). Our
experiments show that 14-3-3ζ binds to the phosphopeptide with a ~1:1 stoichiometry and
27μM Kd, while no binding is observed for the non phosphorylated peptide (Supplementary
Fig. 7). This confirms that the phosphate is directly involved in 14-3-3ζ binding and
indicates a binding mode consistent with the inhibitory effect of difopein observed in our
functional assays.
The experiments described above show that KH1 interacts with 14-3-3 only when the
domain is phosphorylated and unfolded and that, as we previously proposed9, this
interaction is mediated by a short target sequence within the domain.
KSRP phosphorylation leads to nuclear localization
KSRP is known to shuttle between nucleus and cytoplasm in response to extra-cellular
stimuli and its nuclear/cytoplasmic distribution varies substantially depending on cell type
and conditions8,9. 14-3-3ζ is a predominantly nuclear isoform and has been shown to
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change the nuclear localization of, among others, the mRNA decay-promoting factor TTP16.
Therefore we reasoned that binding to 14-3-3ζ may lead to nuclear retention of KSRP and
that nuclear localization may be responsible for the inability of the protein to recruit the
mRNA degradation machinery. In order to assess the effect of Ser193 phosphorylation on
KSRP sub-cellular localization we compared the nucleo/cytoplasm distribution of the
protein in pituitary αT3-1 cells stably expressing a constitutively active AKT1 (myrAKT1)
and in a mock-transfected αT3-1 negative control9. KSRP was similarly distributed in the
S100 cytoplasmic and the nuclear fractions in the mock-αT3-1 cells, while it was mainly
nuclear in the αT3-myrAKT-1 (Figure 7a). These data were confirmed using HIRc-B cells,
in which AKT activation can be induced by insulin treatment (Figure 7b). Here also, AKT
activation promotes nuclear localization of KSRP. The expression of a constitutively active
AKT as well as the activation of endogenous AKT by insulin treatment did not affect the
cellular distribution of the ribo-nucleoproteins AUF1 and hnRNPA1, confirming the
specificity of the effect we observe for KSRP (Figure 7). AKT-driven phosphorylation and
the resulting interaction with 14-3-3ζ mediate the nuclear localization of KSRP, presumably
by sequestering the protein in the nucleus. In order to exclude the involvement of the NLS of
KSRP in its AKT-mediated nuclear retention we transiently transfected in HEK293 cells a
Flag-tagged KSRP deletion mutant that contains the four KH domains but excludes the
NLS. The results presented in Figure 7c indicate that co-expression of myrAKT caused an
enrichment of Flag 1-4 in the nuclear compartment. Importantly, the co-expression of
difopein30, a specific inhibitor of the classical 14-3-3-ligand interaction mode, eliminated
the effect of KSRP (Figure 7c). Also, myrAKT1 expression did not affect the localization of
the Flag-tagged KSRP(S193A) mutant in transiently transfected HEK293 cells (Figure 7d).
Altogether these results highlight the relevance of Ser193 phosphorylation by AKT to the
control of the sub-cellular localization of KSRP.
DISCUSSION
Our results describe, for the first time, a phospho-dependent switch based on the unfolding
of a KH domain, KH1 of KSRP. AKT phosphorylation of KH1 is responsible for its
unfolding, which creates a binding site for 14-3-3. In turn, binding of 14-3-3 results in the
increased nuclear localization of KSRP and therefore decreases its mRNA degradation
activity in the cytoplasm. This work shows that KH domains can function not only as
nucleic acid binding units but as independent regulatory elements and provides a molecular
links between a signaling event and mRNA metabolism.
KH1 phosphorylation and 14-3-3 recruitment
The structure of KSRP KH1 reveals that access to Ser193, whose phosphorylation regulates
14-3-3 binding and mRNA decay, is restricted by an N-terminal extension of the domain and
by the geometry of the β-sheet. However, competition experiments using difopein9 suggest
that 14-3-3 recognizes KH1 using the extended and accessible stretch of amino acids
containing a phosphoserine or phosphothreonine. This apparent contradiction is explained
by the unfolding undergone by the protein upon phosphorylation of Ser193 that creates a
binding site for 14-3-3. Unfolding is not due to the disruption of specific interactions made
by the serine side chain but to a specific role of the negative charged phosphate group. The
phosphomimic S193D mutant is also largely unfolded at 37 °C, while the S193A mutant
used as a negative control in a previous functional study9 shows the same stability as the
wild type protein.
Non-phosphorylated KH1 is not recognized by 14-3-3 while phospho-KH1 interacts with the
protein: once KH1 is phosphorylated and unfolded 14-3-3 can recognize the domain. The
changes observed in the phospho-KH1 spectrum upon 14-3-3 binding are reversed by
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adding a KH1-derived phospho-peptide that contains the 14-3-3 binding site indicating that
the key contacts are provided by a short stretch of amino acids including and flanking
Ser193. Further - and consistently with our functional data - ITC experiments on the
phospho-peptide and its non-phosphorylated version show that only the phospho-peptide
binds to 14-3-3ζ and indicate the phosphate group itself is involved in recognition. This does
not exclude that other parts of KSRP also interact with 14-3-3. Target dimerisation or
binding to additional sites has been observed in 14-3-3–target recognition and the affinity of
the phosphopeptide for 14-3-3ζ (27 μM Kd) indicates that secondary contacts are likely to
occur in vivo.
Structural rearrangement upon phosphorylation is a common regulatory mechanism31, but
there are no reported examples, to our knowledge, of a complete unfolding of an RNA
binding domain. Phosphorylation of a residue at the boundaries of a KH domain has been
reported for the hnRNP K protein, where the Y458D phospho-mimic mutation leads to a
change in protein dynamics and a decrease in RNA binding but does not change the
structure of the domain32. The phosphorylation-mediated unfolding of KH1 represents a
novel regulatory mechanism and could be explained by the atypically low stability of KH1.
The domain structure shields Ser193 not only from 14-3-3 but also from AKT recognition.
However, the appreciable fraction (~16%) of unfolded protein at 37°C facilitates the access
of the AKT kinase to the residue to be phosphorylated. Then the phosphorylation event traps
KH1 in the unfolded conformation and drives the folded/unfolded equilibrium to the
unfolded state. This regulatory mechanism is reversible, as refolding of KH1 can be
achieved by de-phosphorylation of the protein by a phosphatase. Proteomics-derived
patterns of phosphorylation (Phosphosite® database, http://www.phosphosite.org/) indicate
that phosphorylation within the boundaries of a domain is not uncommon for post-
transcriptional regulatory factors: the data presented here could indicate that
phosphorylation-mediated domain unfolding may be common in the control of post-
transcriptional regulatory factors.
Role of KH1 in ARE-mediated mRNA degradation
The in vitro RNA binding ability of KSRP is not affected by KH1 phosphorylation9.
However, we show here that phosphorylation leads to unfolding of KH1 and therefore to the
complete disruption of its RNA binding surface (and presumably of its RNA binding
capability). It follows that the domain is not essential to the interaction between KSRP and
the AU-rich sequences within the mRNAs examined. We have previously shown that a
construct comprising the KH3 and KH4 domains of KSRP binds an AU-rich TNF-α
sequence with high affinity, while the individual domains bind to the protein with sub-mM
Kd7. The proposed combinatorial model of interaction we derived from these data7 can be
extended to involve KH1 and KH2. However, we report here that KH1 interacts with AU-
rich sequences with an affinity substantially lower than that of the other KH domains,
consistently with its reported specificity for GU-rich sequences 33. Furthermore the length of
several of the putative binding sequences fit three, not four, KH domains. It seems likely
that the role of KH1 in the degradation of the mRNAs identified by Ruggiero and
colleagues10 is to connect KSRP-mediated AMD to extra cellular regulatory pathways rather
than to participate in ARE binding.
AKT activation induces a conformational change of KSRP KH1 through the
phosphorylation of Ser193. KH1 unfolds and creates a binding site for the predominantly
nuclear 14-3-3ζ. Interaction with 14-3-3 has been shown to change the subcellular
localization of TTP, a well studied mRNA degradation factor, while interaction with the
14-3-3ζ has been reported to lead to nuclear localization of PKUα protein34 and of the actin-
binding protein myopodin35. We show that in KSRP regulation, phosphorylation of Ser193
leads to nuclear retention of the protein by 14-3-3ζ: our analysis of the nuclear/
Díaz-Moreno et al. Page 7
Nat Struct Mol Biol. Author manuscript; available in PMC 2010 April 22.
U
KPM
C
 Funders G
roup Author M
anuscript
U
KPM
C
 Funders G
roup Author M
anuscript
cytoplasmatic partitioning of the protein shows that activation of AKT leads to nuclear
localization of KSRP. This effect is abolished by mutation of Ser193 by alanine and strongly
reduced by co-expression of difopein together with myrAKT1. Further, nuclear/cytoplasmic
partition of the protein is observed in an NLS independent fashion. How does this
mechanism relate to an impairment of exosome recruitment? The interaction between KSRP
and the exosome has been reported to involve several domains within the protein as well as
several exosomal components6,36,37 and is probably a combination of direct and indirect
interactions within a large multi-component complex. Localization of KSRP into the nucleus
and the disruption of the correct structural setting would impair protein-exosome interaction.
In the model described above the phosphorylated KSRP localizes to the nucleus and is no
longer available to recruit the mRNA degradation machinery. KSRP is a multi-functional
protein involved at several levels of mRNA regulation including mRNA splicing and mRNA
localization38,39. The role of KH1 in the nuclear localization of KSRP is linked to the action
of a specific kinase and influences the stability of a defined subset of mRNAs.
In this work we have used NMR and other biophysical tools to characterize a
phosphorylation-mediated conformational change and to elucidate a new 14-3-3 mediated
regulatory mechanism. In the past few years efforts have been made to link post-
transcriptional regulatory activities to phosphorylation-mediated signaling pathways. The
direct structural characterization of a phosphorylation-mediated rearrangement is an
important step in understanding these processes at a molecular level and indicates that an
unexpectedly high level of complexity exist in the integration of signaling pathways and
RNA metabolism.
METHODS
Protein, peptide and RNA oligonucleotides preparation
The preparation of the different protein samples used in this study is described in the
Supplementary methods section. The KH1 peptide (GLPERSVSLTGAPES) was
synthesized in-house. All RNA oligo-nucleotides were chemically synthesized (Curevac)
and used without further purification.
CD spectroscopy—All CD spectra were recorded on Jasco J-715 spectropolarimeter
equipped with a PTC-348 Peltier temperature-control system. Thermal unfolding was
monitored between 5 °C and 90 °C, 15 °C and 95 °C or 15 °C and 90 °C, depending on the
constructs. Temperature was increased at a rate of 1 °C per min and unfolding was
monitored by recording the signal at 220 nm. Reversibility was assessed by cooling to 5 °C
or 15 °C at the same rate. Protein concentrations were 2-3 μM in 10 mM Tris-HCl buffer
(pH 7.4), 100 mM NaCl, 1 mM TCEP. The data were fit to a two-state (native-denatured)
model with in-house software as described40. For the KH12 construct two independent
unfolding transitions were postulated.
NMR spectroscopy—The preparation of the NMR samples, the recording and processing
of NMR spectra, the assignment of the backbone resonances and the measurament and
analysis of 15N relaxation parameters (T1, T2 and {1H}-15N NOE) are described in the
Supplementary Methods section. The thermal stability of the domains was monitored by
recording 15N-HSQC spectra at 3 °C intervals between 27 °C and 69 °C and is also
described in detail in the Supplementary Methods section. In all cases, the protein unfolding
was fully reversible.
KH1–RNA complex formation was followed by acquiring 15N-HSQC spectra during
titrations of 5′-UAUUUA-3′ and 5′-UAUUAU-3′ RNAs into a sample of 25 μM 15N-labeled
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KH domains in 10 mM Tris-HCl buffer (pH 7.4), 100 mM NaCl, 1 mM TCEP, at 27°C. The
analysis of the data is described in the Supplementary Methods section.
Structure calculation and analysis—Structure calculations were performed with
ARIA 1.241 using dihedral restraints obtained from experimentally measured scalar
couplings (ϕ)42 or from chemical-shift-based TALOS database (ϕ/φ)43 and experimental
distance restraints (Table 1) derived from NOE peak lists compiled in SPARKY44 and
integrated with XEASY45. H-bond constraints were added when identified by structural
analysis (MOLMOL)46 in at least 15 of the 20 preliminary structures. The low stability of
the domain prevented us to extract information on the backbone amide protection
parameters from H2O/D2O exchange experiments.
Two hundred randomized conformers underwent simulated annealing with a standard CNS
protocol as described47. The 25 lowest energy structures were water refined51 and the
structural statistics are shown in Table 1. Structure quality was evaluated by using
PROCHECK-NMR48. 98.6% of residues were in the most favoured/additionally allowed
regions, 0.5% in the generously allowed regions and 0.9% in the disallowed regions.
MOLMOL46 was used to visualize the structure and to create figures. CLUSTALX49 was
used for multiple sequence alignment. DALI (http://www.ebi.ac.uk/dali/)20 was used to
search the PDB for closely related structures while the search of loop-turns structurally
similar to the N-terminal extension within the SCOP40 domain database was undertaken
using a local structure-based alphabet21,22.
KH1 phosphorylation and de-phosphorylation and KH1 peptide
phosphorylation—300 μl of 100 μM KH1130–218 construct were phosphorylated using 1
μg of recombinant active AKT1 enzyme (Upstate Inc.). The reaction was carried out at 37°C
for 48 hours and phosphorylated (~90%) and non-phosphorylated proteins were separated by
gel filtration on a superdex 75 10/300GL column (GE Healthcare).
The identity of the two protein peaks was confirmed by mass spectrometry and the samples
were buffer exchanged into 10 mM Tris-HCl pH 7.4, 50 mM NaCl, 1mM TCEP prior to
NMR analysis. After recording the NMR spectra, phosphorylated KH1 was treated with 100
Units of λ protein phosphatase (New England Biolabs) for 60 minutes at 37 °C. The de-
phosphorylated sample was purified by gel filtration as described above and analyzed by
mass spectrometry. The two controls (heat-inactivated AKT1 and S193A mutant) were
treated as described above.
The KH1-derived peptide was phosphorylated using AKT kinase and a protocol analogous
to the one used for full length KH1. Phosphorylated peptide was then purified by reverse
phase HPLC using a Zorbax C-18 column and employing a linear gradient of acidified
acetonitrile from 5 to 60% over 40 minutes. The phosphorylated peptide was lyophilized and
analyzed by mass spectrometry. A second peptide containing the serine-to-alanine mutation
previously outlined was not phosphorylated in a control reaction.
Prior to mass spectrometry all protein samples were desalted using C18 ZipTips (Millipore,
Watford, UK). They were then analyzed by flow injection on a MictoTOF-Q mass
spectrometer (Bruker, Coventry, UK) using an electro spray source operated in positive ion
mode. Summed spectra were deconvoluted using the maximum entropy module of the Data
Analysis software suite supplied by Bruker.
Isothermal titration calorimetry—ITC experiments were carried out using a VP-ITC
microcalorimeter (Microcal). Data was analyzed using the Origin 7.0-based software
provided by the manufacturers. Briefly, 200 μM 14-3-3ζ was dialyzed in 10mM Tris pH 7.4,
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50 mM NaCl, 1mM TCEP was titrated with 2mM YGLPERSVSpLTGAPES KH1-derived
peptides (phosphorylated and non, from the Department of Biochemistry, University of
Bristol) in the dialysis buffer. All experiments were performed at 30°C.
Sub-cellular localization of KSRP—Exponentially growing mock-αT3-1 or αT3-1-
myrAKT1 cells were collected and resuspended in buffer A (10 mMTris-HCl, pH 7.6, 1mM
MgOAc, 2mM DTT, 1x Complete® and 0.1 mM PMSF). Cells were mechanically disrupted
and nuclear pellet collected by centrifugation (15 min at 500g) and extracted in 450 mM
NaCl, 50 mM Tris-HCl pH 8.0, 1.5 mM MgOAc, 1.5 mM KOAc and 0.5% NP-40. S100
extracts were prepared from supernatants6. Both nuclear and S100 extracts were diluted to a
150 mM salt and 0.5% NP-40 concentrations. FlagKH1-4 (aa 130-525 of the human KSRP
coding sequence) and Flag-KSRP constructs have been utilized previously6,9. The plasmid
expressing difopein has been described previously. Nucleo-cytoplasmic extracts from
transiently transfected HEK293 cells were prepared using the NE-PER®reagents (Pierce).
Accession codes
Protein Data Bank: Coordinates of the best 25 conformers of KH1130–218 domain from
KSRP are available with an accession code 2OPU.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Domain structure and sequence alignment of the KSRP protein
(a) Domain organization of KSRP (top) and constructs used in this study (below). KH
domains are indicated by light grey shadowing. The dark grey shadowing N-terminal to
KH1 indicates an extension of the classical KH fold. (b) Sequence alignment of the four KH
domains of KSRP (top) and of KH1 domains in the FBP2/FBP family (bottom). The rat
(Rattus norvegicus, MARTA1), chicken (Gallus gallus, ZBP2) and frog (Xenopus laevis,
VgRBP71) homologues and the human FUSE binding protein (FBP1), are aligned with
human KSRP. Strictly conserved residues in two or more domains are colored in blue and
green; conservative substitutions of hydrophobic and polar residues are marked in gray and
purple. Yellow boxes point out the position of Ser193; red boxes define the boundaries of
the N-terminal extension at KH1. Secondary structure elements and loops are also shown.
The FBP2 family sequence alignment indicates that a 13-amino acid stretch amino-terminal
to the core KH1 domain is conserved in the FBP2 but not in the FBP family.
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Figure 2. High resolution solution structure of KSRP KH1 domain
(a) 90° rotated ribbon representations of the solution structure of the KSRP KH1130–218
domain. The side-chain of Ser193 on the β3 is displayed in yellow. The N-terminal
extension folds back to join the antiparallel β sheet. (b) Superposition of the KH1 Cα trace
for the 25 lowest energy conformers plus the average structure. (c) Close-up of the β0 - β1
and of the turn0-α3 interactions. The hydrogen bonds between Ser132 HN and Glu148 O,
Ser132 O and Glu148 HN, Leu134 HN and Thr146 O, Leu134 O and Thr146 HN, Pro141 O
and Gly196 HN are indicated by green lines. The side-chains of Pro141 and Gly196 are
displayed. (d) A space-filling (CPK) representation of the close-up in panel (c). The N-tail
extension is in pink with hydrophobic amino acids in yellow. The classical KH fold is in
blue with the Ser193 residue marked in green. The interaction between the two elements
(including the Proline-rich loop) buries ~980Å2 of exposed surface.
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Figure 3. KH1 and KH2 do not make contact
a) Superimposition of 15N-HSQC spectra of KH1143–218 (yellow), KH2233-305 (magenta)
and KH12143–305 (gray). No appreciable chemical-shift perturbations (Δδavg > 0.02 ppm)
are observed between corresponding resonances in the one- and two-domain constructs. The
larger of these shifts are observed for a small (4-5) set of resonances in KH2, and we can
attribute them to very transient contacts between KH2 and the flexible linker. The
comparison of the spectra of KH1, KH2 and KH12 indicates that the two domains are not
interacting. b) Comparison of the backbone 15N T1, T2 and 15N{1H} NOE measurements
for KH1143–218 and KH2233-305 (gray) and KH12143–305 (black). The trend of relaxation
parameters along the sequence is the same in the isolated and two-domain constructs. (c)
220 nm CD signal of KH1130–218, KH2233–305 and KH12130–305 recorded during a thermal
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denaturation experiment. The fitted curves of unfolding are represented in cyan, magenta
and green, respectively and are superimposed on experimental data in gray. Protein
unfolding is reversible in all cases and transition mid-points, marked by a dashed line, do not
change substantial in the two domain construct.
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Figure 4. KH1 phosphorylation by AKT kinase
(a) Superimposition of SOFAST 15N-HMQC spectra of the HPLC-purified non-phospho
(cyan) and phospho (yellow) KH1. The phospho-KH1 is unfolded. (b) Superimposition of
CD spectra of phospho-KH1 recorded at 20 (black), 40 (blue), 60 (green), 80 (red) and 95
(yellow) °C. The spectra do not change substantially at increasing temperatures. (c)
Superimposition of SOFAST 15N-HMQC spectra of non-phospho (cyan), phospho (yellow)
and de-phospho (magenta) KH1 domain. KH1 de-phosphorylation results in refolding of the
domain.
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Figure 5. KH1 S193A and S193D mutants
(a) Superimpositions of 15N-HSQC spectra of KH1 wild type (cyan) to S193A (magenta)
(top) and wild type (cyan) to S193D (yellow) (bottom). With the exception of the resonances
of residues close to Ser193, the S193A spectrum resembles the wild type one. Contrarily,
S193D mutant is partially unfolded with both native and denatured, forms in equilibrium at
27 °C. The shift of the amide resonance of residue 193 is highlighted by arrows in the two
superimpositions. (b) Superimposition of the 220 nm CD signals of KH1 wild type and
S193A (top) and wild type and S193D (bottom) recorded during a temperature unfolding
experiment. The fitted curves are colored as in (a) and superimposed on the experimental
data (grey). For all constructs, protein unfolding is reversible with midpoints indicated by
dashed lines. The S193D mutant is characterized by a lower Tm value compared with KH1
wild type and S193A mutant.
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Figure 6. KH1–14-3-3ζ interaction
(a) Top - Superimposition of SOFAST 15N-HMQC spectra of 15 μM KSRP KH1 (black)
and KH1+14-3-3 1:2 ratio (red). No appreciable change is observed in the spectrum of the
domain. Middle - Superimposition of SOFAST 15N-HMQC spectra of 15 μM phospho-KH1
(cyan) and phospho-KH1+14-3-3 1:2 ratio (magenta). Selected resonances broaden
substantially. Bottom - Superimposition of SOFAST 15N-HMQC spectra of 15 μM
phospho-KH1+14-3-3 1:2 ratio (magenta) and phospho-KH1+14-3-3+KH1 phospho-peptide
1:2:10 ratios (green). The selective broadening caused by the interaction with phospho-KH1
is reversed by addition of the peptide, indicating that the short peptide compete effectively
with the full-length domain. (b) Detail of SOFAST 15N-HMQC spectra of phospho-KH1
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(top), phospho-KH1+14-3-3 1:2 ratio (middle) and phospho-KH1+14-3-3+KH1 phospho-
peptide 1:2:10 ratios (bottom). Selective broadening of one of the two peaks is reversed by
adding the peptide.
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Figure 7. Sub-cellular KSRP localization
(a) Immunoblot analysis of either nuclear or S100 cytoplasmic extracts from either mock-
αT3-1 and αT3-1-myrAKT1 cells with the specified antibodies. Asterisks mark the position
of a non-specific band in anti-AUF1 immunoblot. (b) Immunoblot analysis of either nuclear
or cytoplasmic extract from either control or insulin (10−6 M, 1h)-treated HIRc-B cells using
the indicated antibodies. (c) Immunoblot analysis (antibodies are indicated) of either nuclear
or cytoplasmic extracts from HEK293 cells transiently transfected with Flag-KH1-4 and
either empty vector (mock) or myrAKT1 (AKT1) or myrAKT1 together with difopein
expression vector (AKT1+ difopein). (d) Immunoblot analysis (antibodies are indicated) of
either nuclear or cytoplasmic extracts from HEK293 cells transiently transfected with Flag-
KSRP(S193A) and either empty vector (mock) or myrAKT1 (AKT1).
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Table 1
NMR and refinement statistics for protein structures
Protein
NMR distance and dihedral constraints
Distance constraints
 Total NOE 1815
 Intra-residue 760
 Inter-residue 1055
  Sequential (|i − j| = 1) 392
  Medium-range (|i − j| < 4) 229
  Long-range (|i − j| > 5) 434
  Intermolecular
 Hydrogen bonds 34
Total dihedral angle restraints 119
  ϕ 76
  ψ 43
Structure statistics
Violations (mean ± s.d.)
 Distance constraints (Å) 0.022 ± 0.016
 Dihedral angle constraints (°) 0.345 ± 0.147
 Max. dihedral angle violation (°) 0.042 ± 0.200
 Max. distance constraint violation (Å) 0.44 ± 0.49
Deviations from idealized geometry
 Bond lengths (Å) 0.0044 ± 0.0002
 Bond angles (°) 0.578 ± 0.019
 Impropers (°) 1.680 ± 0.119
Average pairwise r.m.s. deviation, 25 conformers (Å)
 Heavy 1.48 ± 0.25
 Backbone 0.75 ± 0.16
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